Skip to main content
AAN.com
Articles
September 1, 1999

Nutritional status is a prognostic factor for survival in ALS patients

September 1, 1999 issue
53 (5) 1059

Abstract

Objective: To evaluate the occurrence of malnutrition in patients with ALS, to assess the relation of malnutrition to the neurologic deficit, and to determine the impact of nutritional status on patient survival.
Background: Although ALS may be associated with significant malnutrition, the relative impact on patient survival has not yet been well established.
Methods: In a prospective 7-month study of 55 ALS patients in a referral neurology practice, nutritional status was assessed by calculating body mass index. Neurologic evaluation includes four functional scores and identifies the form of disease onset. Slow vital capacity (VC) was also measured.
Results: Occurrence of malnutrition in patients studied was 16.4%. Survival (using the Kaplan–Meier method) was worse for malnourished patients (p < 0.0001), with a 7.7-fold increased risk of death. Using multivariate analysis, only reduced VC (p < 0.0001) and malnutrition (p < 0.01) were found to have significant independent prognostic value. The degree of malnutrition is independent of neurologic scores and of forms of ALS onset.
Conclusion: Nutritional surveillance of ALS patients is very important, both in bulbar-onset and spinal-onset patients.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Lee JR-J, Annegers JF, Appel SH. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci 1995;132:207–215.
2.
Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr 1996;63:130–137.
3.
Depaul R, Abbs JH. Manifestations of ALS in the cranial motor nerves. Dynametric, neuropathologic, and speech motor data. Neurol Clin 1987;5:231–250.
4.
Norris FH, Shepherd R, Denys E, et al. Onset, natural history and outcome in idiopathic adult motor neurone disease. J Neurol Sci 1993;118:48–55.
5.
Robbins J. Swallowing in ALS and motor neurone disorders. Neurol Clin 1987;5:213–229.
6.
Slowie LA, Paige MS, Antel JP. Nutritional considerations in the management of patients with amyotrophic lateral sclerosis (ALS). J Am Diet Assoc 1983;83:44–47.
7.
Subcommittee on Motor Neurone Disease/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases, El Escorial Clinical Limits of Amyotrophic Lateral Sclerosis Workshop contributors.El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124 (suppl):96–107.
8.
Andersen PK, Keiding N. Survival analysis, overview. In: Armitage P, Colton T, ed. Encyclopedia of biostatistics. Chichester, UK:Wiley, 1998:4452–4461.
9.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.
10.
Aid to the investigation of peripheral nerve injuries. In: Medical Research Council, ed. War memorandum, 2nd ed., revised. London: His Majesty’s Stationery Office, 1943:11–46.
11.
Norris FH Jr. Charting the course in amyotrophic lateral sclerosis. In: Rose FC, ed. Amyotrophic lateral sclerosis. New York:Demos, 1990:83–92.
12.
The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group.The Amyotrophic Lateral Sclerosis Functional Rating Scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 1996;53:141–147.
13.
Bensimon G, Lacomblez L, Meininger V, the ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994;330:585–591.
14.
Torun B, Chew F. Protein–energy malnutrition. In: Shils ME, Olson JA, Shike M, eds. Modern nutrition in health and disease. 8th ed., vol. II. Philadelphia: Lea & Febiger, 1993:959–960.
15.
Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972;34:187–220.
16.
Mazzini L, Corra T, Zaccala M, Mora G, Del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 1995;242:695–698.
17.
Nau KL, Bromberg MB, Forshew DA, Katch VL. Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci 1995;129 (suppl):47–49.
18.
Shimizu T, Hayashi H, Tanabe H. Energy metabolism of ALS patients under mechanical ventilation and tube feeding. Clin Neurol 1991;31:255–259.
19.
Scarpa M, Colombo A, Panzetti P, Sorgato P. Epidemiology of amyotrophic lateral sclerosis in the province of Modena, Italy. Influence of environmental exposure to lead. Acta Neurol Scand 1988;77:456–460.
20.
Leigh PN, Ray–Chaudhuri K. Motor neurone disease. J Neurol Neurosurg Psychiatry 1994;57:886–896.
21.
Preux PM, Couratier P, Boutros–Toni F, et al. Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors. Neuroepidemiology 1996;15:153–160.
22.
Chazot F, Vallat JM, Hugon J, Lubeau M, Dumas M. Amyotrophic lateral sclerosis in Limousin. Neuroepidemiology 1986;5:39–46.
23.
Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival predication. Brain 1995;118:707–719.
24.
James WPT, Ferro–Luzzi A, Waterlow JC. Definition of chronic energy deficiency in adults. Eur J Clin Nutr 1988;42:969–981.
25.
Kasarskis EJ, Neville HE. Management of ALS: nutritional care. Neurology 1996;47 (suppl 2):S118–S120.
26.
Ringel SP, Murphy JR, Alderson MK, et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993;43:1316–1322.
27.
Treatment trials. In: Mitsumoto H, Chad DA, Pioro EP, eds. Amyotrophic lateral sclerosis; contemporary neurology series. Philadelphia: FA Davis, 1998:329–359.
28.
The ALS CNTF Treatment Study (ACTS) Group.Prognostic indicators of survival in amyotrophic lateral sclerosis. Neurology 1996;46:A208. Abstract.
29.
Jeejeebhoy KN. Muscle function and nutrition. Gut 1986;27 (suppl 1):25–39.

Information & Authors

Information

Published In

Neurology®
Volume 53Number 5September 1, 1999
Pages: 1059
PubMed: 10496266

Publication History

Received: May 8, 1998
Accepted: April 24, 1999
Published online: September 1, 1999
Published in print: September 1, 1999

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

J.C. Desport, MD
From the Services of Hépato-Gastroentérologie (Drs. Desport and Sautereau) and Neurologie (Drs. TruongVallat, and Couratier), Centre Hospitalier Universitaire Dupuytren; and the Laboratoire de Biostatistique (Dr. Preux), Faculté de Médecine, Limoges, France.
P.M. Preux, MD
From the Services of Hépato-Gastroentérologie (Drs. Desport and Sautereau) and Neurologie (Drs. TruongVallat, and Couratier), Centre Hospitalier Universitaire Dupuytren; and the Laboratoire de Biostatistique (Dr. Preux), Faculté de Médecine, Limoges, France.
T.C. Truong, MD
From the Services of Hépato-Gastroentérologie (Drs. Desport and Sautereau) and Neurologie (Drs. TruongVallat, and Couratier), Centre Hospitalier Universitaire Dupuytren; and the Laboratoire de Biostatistique (Dr. Preux), Faculté de Médecine, Limoges, France.
J.M. Vallat, MD
From the Services of Hépato-Gastroentérologie (Drs. Desport and Sautereau) and Neurologie (Drs. TruongVallat, and Couratier), Centre Hospitalier Universitaire Dupuytren; and the Laboratoire de Biostatistique (Dr. Preux), Faculté de Médecine, Limoges, France.
D. Sautereau, MD
From the Services of Hépato-Gastroentérologie (Drs. Desport and Sautereau) and Neurologie (Drs. TruongVallat, and Couratier), Centre Hospitalier Universitaire Dupuytren; and the Laboratoire de Biostatistique (Dr. Preux), Faculté de Médecine, Limoges, France.
P. Couratier, MD, PhD
From the Services of Hépato-Gastroentérologie (Drs. Desport and Sautereau) and Neurologie (Drs. TruongVallat, and Couratier), Centre Hospitalier Universitaire Dupuytren; and the Laboratoire de Biostatistique (Dr. Preux), Faculté de Médecine, Limoges, France.

Notes

Address correspondence and reprint requests to Dr. J.C. Desport, UF Nutrition, Service d’Hépato-Gastroentérologie, Centre Hospitalier Universitaire Dupuytren, 87042 Limoges Cedex, France.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. A Glutamate Scavenging Protocol Combined with Deanna Protocol in SOD1-G93A Mouse Model of ALS, Nutrients, 15, 8, (1821), (2023).https://doi.org/10.3390/nu15081821
    Crossref
  2. Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models, Biomolecules, 13, 5, (863), (2023).https://doi.org/10.3390/biom13050863
    Crossref
  3. Management of motor neuron disease with updated therapies: A review, IP Indian Journal of Neurosciences, 9, 1, (1-7), (2023).https://doi.org/10.18231/j.ijn.2023.001
    Crossref
  4. Body mass index and survival from amyotrophic lateral sclerosis, Neurology Clinical Practice, 8, 5, (437-444), (2023)./doi/10.1212/CPJ.0000000000000521
    Abstract
  5. Impact of diabetes mellitus on the respiratory function of amyotrophic lateral sclerosis patients, European Journal of Neurology, (2023).https://doi.org/10.1111/ene.16129
    Crossref
  6. Diagnostic delay in amyotrophic lateral sclerosis, European Journal of Neurology, 30, 9, (2595-2601), (2023).https://doi.org/10.1111/ene.15874
    Crossref
  7. Prognostic Value of Regular Nutritional Treatment in Patients With Amyotrophic Lateral Sclerosis, The Neurologist, 28, 3, (166-172), (2023).https://doi.org/10.1097/NRL.0000000000000460
    Crossref
  8. Increased total daily energy expenditure in mild to moderate ALS: greater contribution from physical activity energy expenditure than hyper-metabolism, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24, 7-8, (661-668), (2023).https://doi.org/10.1080/21678421.2023.2240377
    Crossref
  9. Neuroprognostication for Patients with Amyotrophic Lateral Sclerosis: An Updated, Evidence-Based Review, Seminars in Neurology, 43, 05, (776-790), (2023).https://doi.org/10.1055/s-0043-1775595
    Crossref
  10. Profiles of Dysarthria and Dysphagia in Individuals With Amyotrophic Lateral Sclerosis, Journal of Speech, Language, and Hearing Research, 66, 1, (154-162), (2023).https://doi.org/10.1044/2022_JSLHR-22-00312
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share